ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Angelini Pharma, INC.

Official 2024 U.S. DOL Form 5500 summary for Angelini Pharma, INC. (Angelini Pharma, INC. 401k · EIN 13-3135070 · PN 001): $9.02M net assets, 119 active participants, and $11.72 per $10,000 (11.72 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAngelini Pharma, INC.
Filing IdentifierAngelini Pharma, INC. 401k · EIN 13-3135070 · PN 001
Plan Category & State401(k) Defined Contribution (GA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$9.02M
Active Participants119
Direct Admin Fee Rate$11.72 per $10,000 (11.72 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderAscensus (incl. Newport Group)
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($892,237, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI